source
- AstraZeneca shares drop 5.5% as investors react to reported merger talks with Bristol Myers SquibbAstraZeneca's share price slipped on Monday after Reuters reported that the company is in merger talks with Bristol Myers Squibb. The potential combination would create a drugmaker valued at rough…
- BioNTech appoints Guido Oelkers as new CEO, succeeding cofounder Ugur SahinBioNTech announced that Guido Oelkers will become its chief executive officer, taking over from cofounder Ugur Sahin. Oelkers comes from Swedish biopharma Sobi, where he led the company, and bring…